a protein kinase of the STE20 family that regulates cell motility and morphology. Critical RhoGTPase effector that regulates cytoskeleton reorganization, the JNK MAPK pathway, and nuclear signaling. Binding of Rac/cdc42 to the PBD of PAK1 causes autophosphorylation and conformational change. Phosphorylated and activated by PDK. Note: This description may include information from UniProtKB.
Protein type: Kinase, protein; EC 220.127.116.11; Protein kinase, Ser/Thr (non-receptor); Protein kinase, STE; STE group; STE20 family; PAKA subfamily
Molecular Function: ATP binding; catalytic activity; collagen binding; kinase activity; nucleotide binding; protein binding; protein kinase activity; protein kinase binding; protein serine/threonine kinase activity; Rac GTPase binding; transferase activity
Biological Process: actin cytoskeleton organization and biogenesis; actin cytoskeleton reorganization; activation of protein kinase activity; amygdala development; apoptosis; branching morphogenesis of a tube; cell migration; cellular response to insulin stimulus; dendrite development; exocytosis; metabolic process; neurite morphogenesis; neuromuscular junction development; phosphorylation; positive regulation of cell migration; positive regulation of estrogen receptor signaling pathway; positive regulation of JNK activity; positive regulation of peptidyl-serine phosphorylation; positive regulation of protein amino acid phosphorylation; positive regulation of stress fiber formation; protein amino acid autophosphorylation; protein amino acid phosphorylation; receptor clustering; regulation of actin cytoskeleton organization and biogenesis; regulation of apoptosis; regulation of gene expression; regulation of MAPKKK cascade; regulation of mitotic cell cycle; response to hypoxia; response to organic substance; Rho protein signal transduction; stress-activated protein kinase signaling pathway; wound healing
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.